Frequency of cross-resistance to rilpivirine and etravirine among HIV-1 subtype C infected individuals failing nevirapine/efavirenz based ART regimen

V. V. RamalingamDepartment of Clinical Virology, Christian Medical College, Vellore, India;

J. P. DemosthenesDepartment of Clinical Virology, Christian Medical College, Vellore, India;

B. C. GhaleDepartment of Clinical Virology, Christian Medical College, Vellore, India;

P. RupaliDepartment of Infectious Diseases, Christian Medical College, Vellore, India;

G. M. VargheseDepartment of Infectious Diseases, Christian Medical College, Vellore, India;

O. C. AbrahamDepartment of Medicine, Christian Medical College, Vellore, India

R. KannangaiDepartment of Clinical Virology, Christian Medical College, Vellore, India; Correspondence[email protected]

show all

Click to increase image sizeClick to decrease image size

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Frequency of cross-resistance to rilpivirine and etravirine among HIV-1 subtype C infected individuals failing nevirapine/efavirenz based ART regimen

Information for

Open access

Opportunities

Help and information

Frequency of cross-resistance to rilpivirine and etravirine among HIV-1 subtype C infected individuals failing nevirapine/efavirenz based ART regimen

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature